Publisher: Icon Group International, Inc.
Category: Autoimmune

Autoimmune market research reports by Icon Group International, Inc.

(24 reports matching your criteria)
    • The 2025-2030 World Outlook for Therapeutic Plasma Exchange for Neurological Disorders

      The 2025-2030 World Outlook for Therapeutic Plasma Exchange for Neurological Disorders This study covers the world outlook for therapeutic plasma exchange for neurological disorders across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential indust ... Read More

    • The 2025-2030 World Outlook for Lupus Drugs

      The 2025-2030 World Outlook for Lupus Drugs This study covers the world outlook for lupus drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the p ... Read More

    • The 2025-2030 World Outlook for Intravenous Immunoglobulin for Guillain-Barre Syndromes

      The 2025-2030 World Outlook for Intravenous Immunoglobulin for Guillain-Barre Syndromes This study covers the world outlook for intravenous immunoglobulin for guillain-Barre syndromes across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential indu ... Read More

    • The 2025-2030 World Outlook for Primary Immunodeficiency

      The 2025-2030 World Outlook for Primary Immunodeficiency This study covers the world outlook for primary immunodeficiency across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millio ... Read More

    • The 2025-2030 World Outlook for Primary Immunodeficiency Diseases

      The 2025-2030 World Outlook for Primary Immunodeficiency Diseases This study covers the world outlook for primary immunodeficiency diseases across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in q ... Read More

    • The 2025-2030 World Outlook for Subcutaneous Immunoglobulins

      The 2025-2030 World Outlook for Subcutaneous Immunoglobulins This study covers the world outlook for subcutaneous immunoglobulins across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (i ... Read More

    • The 2025-2030 World Outlook for Guillain-Barre Syndrome Therapeutics

      The 2025-2030 World Outlook for Guillain-Barre Syndrome Therapeutics This study covers the world outlook for guillain-Barre syndrome therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the countr ... Read More

    • The 2025-2030 World Outlook for Systemic Lupus Erythematosus (SLE) Drugs

      The 2025-2030 World Outlook for Systemic Lupus Erythematosus (SLE) Drugs This study covers the world outlook for systemic Lupus erythematosus (SLE) drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for th ... Read More

    • The 2025-2030 World Outlook for Systematic Lupus Erythematosus Treatments

      The 2025-2030 World Outlook for Systematic Lupus Erythematosus Treatments This study covers the world outlook for systematic Lupus erythematosus treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for ... Read More

    • The 2025-2030 World Outlook for Autoimmune Disorder Diagnostics

      The 2025-2030 World Outlook for Autoimmune Disorder Diagnostics This study covers the world outlook for autoimmune disorder diagnostics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in quest ... Read More

    • The 2025-2030 World Outlook for Immunoglobulins

      The 2025-2030 World Outlook for Immunoglobulins This study covers the world outlook for immunoglobulins across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars ... Read More

    • The 2025-2030 World Outlook for Anti-Inflammatory Lupus Drugs

      The 2025-2030 World Outlook for Anti-Inflammatory Lupus Drugs This study covers the world outlook for anti-inflammatory Lupus drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question ... Read More

    • The 2025-2030 World Outlook for Autoimmune Disease Diagnostic Consumables and Assay Kits

      The 2025-2030 World Outlook for Autoimmune Disease Diagnostic Consumables and Assay Kits This study covers the world outlook for autoimmune disease diagnostic consumables and assay kits across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential in ... Read More

    • The 2025-2030 World Outlook for Autoimmune Disease Therapeutics

      The 2025-2030 World Outlook for Autoimmune Disease Therapeutics This study covers the world outlook for autoimmune disease therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in quest ... Read More

    • The 2025-2030 World Outlook for Systemic Lupus Erythematosus

      The 2025-2030 World Outlook for Systemic Lupus Erythematosus This study covers the world outlook for systemic Lupus erythematosus across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (i ... Read More

    • The 2025-2030 World Outlook for Autoimmune Treatments

      The 2025-2030 World Outlook for Autoimmune Treatments This study covers the world outlook for autoimmune treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of ... Read More

    • The 2025-2030 World Outlook for Autoimmune Disease Diagnostics

      The 2025-2030 World Outlook for Autoimmune Disease Diagnostics This study covers the world outlook for autoimmune disease diagnostics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in questio ... Read More

    • The 2025-2030 World Outlook for Progressive Multifocal Leukoencephalopathy Treatments

      The 2025-2030 World Outlook for Progressive Multifocal Leukoencephalopathy Treatments This study covers the world outlook for progressive multifocal leukoencephalopathy treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry ... Read More

    • The 2025-2030 World Outlook for Intravenous Immunoglobulins

      The 2025-2030 World Outlook for Intravenous Immunoglobulins This study covers the world outlook for intravenous immunoglobulins across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in ... Read More

    • The 2025-2030 World Outlook for Primary Immunodeficiency Disease Tests

      The 2025-2030 World Outlook for Primary Immunodeficiency Disease Tests This study covers the world outlook for primary immunodeficiency disease tests across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the co ... Read More

    • The 2025-2030 World Outlook for Monocyte Activation Test Kits

      The 2025-2030 World Outlook for Monocyte Activation Test Kits This study covers the world outlook for monocyte activation test kits across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question ... Read More

    • The 2025-2030 World Outlook for Anti-Inflammatory Autoimmune Disease Therapeutics

      The 2025-2030 World Outlook for Anti-Inflammatory Autoimmune Disease Therapeutics This study covers the world outlook for anti-inflammatory autoimmune disease therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earning ... Read More

    • The 2025-2030 World Outlook for Lupus Therapeutics

      The 2025-2030 World Outlook for Lupus Therapeutics This study covers the world outlook for lupus therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. d ... Read More

    • The 2025-2030 World Outlook for Plasma Fractionation of Intravenous Immunoglobulins

      The 2025-2030 World Outlook for Plasma Fractionation of Intravenous Immunoglobulins This study covers the world outlook for plasma fractionation of intravenous immunoglobulins across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry ear ... Read More

Research Assistance

Live help

Join Alert Me Now!

Sign Up

Find out more on our blog
Cookie Settings